Ventilator-Associated Pneumonia in a Tertiary Care Intensive Care Unit: Analysis of Incidence, Micro-Biological Profile, Resistant Pattern and Outcome

Background: Ventilator-associated pneumonia (VAP) is the most common nosocomial infection diagnosed in the intensive care unit (ICU). The aim is to determine the incidence, bacteriology and resistant pattern and 28 days mortality in intensive care unit. Methods: This prospective study was conducted in intensive care unitfrom July 2017 through June 2018. All the patients who were on mechanical ventilation for >48 h in the ICU during the study period were enrolled. VAP was diagnosed according to the Centre for Disease Control (CDC) criteria. Fisher's exact test was applied to compare two or more set of variables.P-value less than 0.05 was considered to be statistically significant. Results: A total of 117 patients were included in the study and VAP developed in 49 patients with an incidence of VAP 0.42% episodes of infection/1000 mechanical ventilation days(95% Confidence Interval: 0.32 to 0.514).These were predominantly caused by Gram-negative organisms and the most common organism isolated was Acinetobacter baumanii(12 isolates,40%). Acinetobacter baumanii infection was associated with prolonged ICU stay(P value 0.009).Colistin was the most effective drug in our study and found to be effective in >90% of the patients. The overall mortality of VAP patients in our study was 36.7%. Patients with underlying diabetes mellitus and hypertension had adverse outcome in comparison to the patients without underlying comorbidity (P value=0.017). Conclusions: VAP continues to be a major threat to patients who are admitted for mechanical ventilation into the critical care unit, emphasizing the urgent need for infection control measures.

[1]  S. Kadam,et al.  Clinical study of ventilator-associated pneumonia in tertiary care hospital, Kolhapur, Maharashtra, India , 2017 .

[2]  E. Larson,et al.  Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii , 2015, Antimicrobial Resistance and Infection Control.

[3]  Fei Wang,et al.  Colistin for the treatment of ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: a systematic review and meta-analysis. , 2014, International journal of antimicrobial agents.

[4]  Muktikesh Dash,et al.  Frequency, risk factors, and antibiogram of Acinetobacter species isolated from various clinical samples in a tertiary care hospital in Odisha, India , 2013, Avicenna Journal of Medicine.

[5]  Navneet Singh,et al.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations. , 2012 .

[6]  Meng-Chih Lin,et al.  An early predictor of the outcome of patients with ventilator-associated pneumonia. , 2010, Chang Gung medical journal.

[7]  Mauricio Valencia,et al.  Ventilator-associated pneumonia , 2009, Current opinion in critical care.

[8]  D. Cook,et al.  Endotracheal aspiration in the diagnosis of ventilator-associated pneumonia. , 2000, Chest.

[9]  A. Ruffell,et al.  Ventilator-associated pneumonia: prevention is better than cure. , 2008, Nursing in critical care.

[10]  L. Kennedy Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study , 2008 .